Show simple item record

dc.contributor.authorTutt, Aen_US
dc.date.accessioned2018-01-24T11:27:18Z
dc.date.issued2018-01en_US
dc.identifier.citationAnnals of oncology : official journal of the European Society for Medical Oncology, 2018, 29 (1), pp. 18 - 21en_US
dc.identifier.issn0923-7534en_US
dc.identifier.urihttps://repository.icr.ac.uk/handle/internal/1010
dc.identifier.eissn1569-8041en_US
dc.identifier.doi10.1093/annonc/mdx775en_US
dc.formatPrinten_US
dc.format.extent18 - 21en_US
dc.languageengen_US
dc.language.isoengen_US
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/en_US
dc.subjectHumansen_US
dc.subjectBreast Neoplasmsen_US
dc.subjectNeoplasm Recurrence, Localen_US
dc.subjectPaclitaxelen_US
dc.subjectCarboplatinen_US
dc.subjectBenzimidazolesen_US
dc.subjectTemozolomideen_US
dc.titleInhibited, trapped or adducted: the optimal selective synthetic lethal mix for BRCAness.en_US
dc.typeJournal Article
dcterms.dateAccepted2017-10-18en_US
rioxxterms.versionofrecord10.1093/annonc/mdx775en_US
rioxxterms.licenseref.urihttps://creativecommons.org/licenses/by-nc/4.0en_US
rioxxterms.licenseref.startdate2018-01en_US
rioxxterms.typeJournal Article/Reviewen_US
dc.relation.isPartOfAnnals of oncology : official journal of the European Society for Medical Oncologyen_US
pubs.issue1en_US
pubs.notesNot knownen_US
pubs.organisational-group/ICR
pubs.publication-statusPublisheden_US
pubs.volume29en_US
pubs.embargo.termsNot knownen_US
dc.contributor.icrauthorTutt, Andrewen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

http://creativecommons.org/licenses/by/4.0/
Except where otherwise noted, this item's license is described as http://creativecommons.org/licenses/by/4.0/